These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 26718936)

  • 1. Optimal cutoff points for HOMA-IR and QUICKI in the diagnosis of metabolic syndrome and non-alcoholic fatty liver disease: A population based study.
    Motamed N; Miresmail SJ; Rabiee B; Keyvani H; Farahani B; Maadi M; Zamani F
    J Diabetes Complications; 2016 Mar; 30(2):269-74. PubMed ID: 26718936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The value of different insulin resistance indices in assessment of non-alcoholic fatty liver disease in overweight/obese children.
    El-Karaksy HM; El-Raziky MS; Fouad HM; Anwar GM; El-Mougy FM; El-Koofy NM; El-Hennawy AM
    Diabetes Metab Syndr; 2015; 9(2):114-9. PubMed ID: 25470627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fatty liver index vs waist circumference for predicting non-alcoholic fatty liver disease.
    Motamed N; Sohrabi M; Ajdarkosh H; Hemmasi G; Maadi M; Sayeedian FS; Pirzad R; Abedi K; Aghapour S; Fallahnezhad M; Zamani F
    World J Gastroenterol; 2016 Mar; 22(10):3023-30. PubMed ID: 26973398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutoff values of surrogate measures of insulin resistance for metabolic syndrome in Korean non-diabetic adults.
    Lee S; Choi S; Kim HJ; Chung YS; Lee KW; Lee HC; Huh KB; Kim DJ
    J Korean Med Sci; 2006 Aug; 21(4):695-700. PubMed ID: 16891815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Predictors of liver fibrosis in patients with non-alcoholic fatty liver disease. The role of metabolic syndrome, insulin-resistance and inflammation].
    Andreozzi P; Viscogliosi G; Colella F; Subic M; Cipriani E; Marigliano B; Verrusio W; Servello A; Ettorre E; Marigliano V
    Recenti Prog Med; 2012 Dec; 103(12):570-4. PubMed ID: 23258240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defining a cutoff point for vitamin D deficiency based on insulin resistance in children.
    Sharifi F; Mousavinasab N; Mellati AA
    Diabetes Metab Syndr; 2013; 7(4):210-3. PubMed ID: 24290086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrasonographically detected non-alcoholic fatty liver disease is an independent predictor for identifying patients with insulin resistance in non-obese, non-diabetic middle-aged Asian adults.
    Sinn DH; Gwak GY; Park HN; Kim JE; Min YW; Kim KM; Kim YJ; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC
    Am J Gastroenterol; 2012 Apr; 107(4):561-7. PubMed ID: 22108448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single Point Insulin Sensitivity Estimator in Pediatric Non-Alcoholic Fatty Liver Disease.
    Furthner D; Anderwald CH; Bergsten P; Forslund A; Kullberg J; Ahlström H; Manell H; Ciba I; Mangge H; Maruszczak K; Koren P; Schütz S; Brunner SM; Schneider AM; Weghuber D; Mörwald K
    Front Endocrinol (Lausanne); 2022; 13():830012. PubMed ID: 35185803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The threshold value of homeostasis model assessment for insulin resistance in Qazvin Metabolic Diseases Study (QMDS): assessment of metabolic syndrome.
    Ziaee A; Esmailzadehha N; Oveisi S; Ghorbani A; Ghanei L
    J Res Health Sci; 2015; 15(2):94-100. PubMed ID: 26175291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is HOMA-IR a potential screening test for non-alcoholic fatty liver disease in adults with type 2 diabetes?
    Gutierrez-Buey G; Núñez-Córdoba JM; Llavero-Valero M; Gargallo J; Salvador J; Escalada J
    Eur J Intern Med; 2017 Jun; 41():74-78. PubMed ID: 28283346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of HOMA-IR to diagnose non-alcoholic fatty liver disease: a population-based and inter-laboratory study.
    Isokuortti E; Zhou Y; Peltonen M; Bugianesi E; Clement K; Bonnefont-Rousselot D; Lacorte JM; Gastaldelli A; Schuppan D; Schattenberg JM; Hakkarainen A; Lundbom N; Jousilahti P; Männistö S; Keinänen-Kiukaanniemi S; Saltevo J; Anstee QM; Yki-Järvinen H
    Diabetologia; 2017 Oct; 60(10):1873-1882. PubMed ID: 28660493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison between HOMA-IR and ISI-gly in detecting subjects with the metabolic syndrome.
    Carnevale Schianca GP; Sainaghi PP; Castello L; Rapetti R; Limoncini AM; Bartoli E
    Diabetes Metab Res Rev; 2006; 22(2):111-7. PubMed ID: 16052601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Non-alcoholic Fatty Liver Disease with Metabolic Syndrome Independently of Central Obesity and Insulin Resistance.
    Yang KC; Hung HF; Lu CW; Chang HH; Lee LT; Huang KC
    Sci Rep; 2016 Jun; 6():27034. PubMed ID: 27246655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The usefulness of metabolic score for insulin resistance for the prediction of incident non-alcoholic fatty liver disease in Korean adults.
    Lee JH; Park K; Lee HS; Park HK; Han JH; Ahn SB
    Clin Mol Hepatol; 2022 Oct; 28(4):814-826. PubMed ID: 35680169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic values of metabolic syndrome definitions for detection of insulin resistance: Tehran Lipid and Glucose Study (TLGS).
    Hosseinpanah F; Borzooei S; Barzin M; Farshadi M; Sarvghadi F; Azizi F
    Arch Iran Med; 2012 Oct; 15(10):606-10. PubMed ID: 23020535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of indices of insulin resistance with metabolic syndrome classifications to predict the development of impaired fasting glucose in overweight and obese subjects: a 3-year prospective study.
    Shand BI; Scott RS; Lewis JG; Elder PA; Frampton CM
    Int J Obes (Lond); 2009 Nov; 33(11):1274-9. PubMed ID: 19721448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of different metabolic syndrome classifications on the metabolic syndrome prevalence in a young Middle Eastern population.
    Chedid R; Gannagé-Yared MH; Khalifé S; Halaby G; Zoghbi F
    Metabolism; 2009 Jun; 58(6):746-52. PubMed ID: 19446111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between serum α-L-fucosidase and non-alcoholic fatty liver disease: Cross-sectional study.
    Lu ZY; Cen C; Shao Z; Chen XH; Xu CF; Li YM
    World J Gastroenterol; 2016 Feb; 22(5):1884-90. PubMed ID: 26855548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spectrum of insulin sensitivity in the Korean population.
    Ryu S; Sung KC; Chang Y; Lee WY; Rhee EJ
    Metabolism; 2005 Dec; 54(12):1644-51. PubMed ID: 16311099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of Aspartate Aminotranferase and Tumor Necrosis Factor-α as Non Invasive Diagnostic Tools for Non Alcoholic Steatohepatitis (NASH).
    Purnomo HD; Mundhofir FE; Kasno ; Sudijanto E; Darmono ; Daldiyono ; Djokomoeljanto R; Faradz SM
    Acta Med Indones; 2015 Jan; 47(1):16-23. PubMed ID: 25948763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.